Taurine: New implications for an old amino acid

FEMS Microbiology Letters

Volumn 226, Issue 2, 2003, Pages 195-202

  Schuller Levis, Georgia B ^a   Park, Eunkyue ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Cysteine sulfinic acid decarboxylase; Inflammatory mediator; Nitric oxide; Taurine; Taurine chloramine; Taurolidine; Tumor necrosis factor

Indexed keywords

AMINO ACID; CHLORAMINE DERIVATIVE; CYSTEINE; CYSTEINE DIOXYGENASE; CYTOKINE; HYPOCHLOROUS ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; NEUTROLIN; NICOTINIC ACID; OXIDIZING AGENT; OXYGENASE; SCATTER FACTOR RECEPTOR; TAURINE; TAURINE CHLORAMINE; TAUROLIDINE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AUTACOID; CARBOXYLYASE; CARRIER PROTEIN; CHUK PROTEIN, HUMAN; DRUG DERIVATIVE; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; MEMBRANE PROTEIN; N CHLOROTAURINE; N-CHLOROTAURINE; PROTEIN SERINE THREONINE KINASE; SULFOALANINE DECARBOXYLASE; TAURINE TRANSPORTER; THIADIAZINE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CANCER THERAPY; DOSE RESPONSE; DOWN REGULATION; DRUG HALF LIFE; ENDOTOXEMIA; FERTILITY; GENETIC MANIPULATION; GLUTATHIONE METABOLISM; HUMAN; IMMUNITY; INFECTION; INJURY; LIVER; LUNG INJURY; MEDIATOR RELEASE; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROTECTION; PROTEIN DEGRADATION; RETINA DEGENERATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TOXICITY; TUMOR; VISUAL IMPAIRMENT; AMINO ACID SEQUENCE; ANIMAL; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW;

BOVINAE; MAMMALIA; RODENTIA;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CARBOXY-LYASES; CARRIER PROTEINS; HUMANS; I-KAPPA B KINASE; INFLAMMATION MEDIATORS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; TAURINE; THIADIAZINES;

EID: 0642285743     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00611-6     Document Type: Short Survey

References (47)

1. Huxtable R.J. The physiological actions of taurine. Physiol. Rev. 72:1992;101-163.
2. Sturman J.A. Taurine in development. Physiol. Rev. 73:1993;119-148.
3. Schuller-Levis G., Mehta P.D., Rudelli R., Sturman J.A. Immunologic consequence of taurine deficiency in cats. J. Leukoc. Biol. 47:1990;321-333.
4. Fukuda K., Hirai Y., Yoshida H., Hakajima T., Usii T. Free-amino acid content of lymphocytes and granulocytes compared. Clin. Chem. 28:1982;1758-1761.
5. Parcell S. Sulfur in human nutrition and applications in medicine. Altern. Med. Rev. 7:2002;22-44.
6. Watson R.W.G., Redmond H.P., McCarthy J., Bouchier-Hayes D. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine. J. Leukoc. Biol. 58:1995;299-306.
7. Bedrosian I., Sofia R.D., Wolff S.M., Dinarello C.A. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine. 3:1991;568-575.
8. Da Costa M.L., Redmond H.P., Bouchier-Hayes D.J. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. J. Surg. Res. 101:2001;111-119.
9. McCourt M., Wang J.H., Sookhai S., Redmond H.P. Taurolidine inhibits tumor cell growth in vitro and in vivo. Ann. Surg. Oncol. 7:2000;685-691.
10. Egan B.M., Abdih H., Kelly C.J., Condron C., Bouchier-Hayes D.J. Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur. J. Surg. 167:2001;575-580.
11. Chiarla C., Giovannini I., Siegel J.H., Boldrini G., Castagneto M. The relationship between plasma taurine and other amino acid levels in human sepsis. J. Nutr. 130:2000;2222-2227.
12. Shinwell E.D., Gorodischer R. Totally vegetarian diets and infant nutrition. Pediatrics. 70:1982;582-586.
13. 2-induced alterations. Am. J. Pathol. 125:1986;585-600.
14. Wang Q., Giri S.N., Hyde D.M., Li C. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem. Pharmacol. 42:1991;1115-1122.
15. Gurujcyalakshmi G., Wang Y., Giri S.N. Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. Nitric Oxide. 4:2000;399-411.
16. Gordon, R.E., Heller, R. and Heller, R. (1992) Taurine production of lungs in hamster models of oxidant-injury: A morphologic time study of paraquat and bleomycin treatment. In: Taurine, Nutritional Value and Mechanisms of Action (Lomhardine, J. et al., Eds.), pp. 319-328. Plenum Press, New York.
17. Schuller-Levis G., Quinn M.R., Wright C., Park E. Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. Adv. Exp. Med. Biol. 359:1994;31-39.
18. Schuller-Levis G., Gordon R.E., Wang C., Park E. Taurine reduces lung inflammation and fibrosis caused by bleomycin. Adv. Exp. Med. Biol. 526:2003;395-402.
19. Abdih H., Kelly C.J., Bouchier-Hayes D., Barry M., Kearns S. Taurine prevents interleukin-2-induced acute lung injury in rats. Eur. Surg. Res. 32:2000;347-352.
20. Egan B.M., Chen G., Kelly C.J., Bouchier-Hayes D.J. Taurine attenuates LPS-induced rolling and adhesion in rat microcirculation. J. Surg. Res. 95:2001;85-91.
21. Cantin A.M. Taurine modulation of hypochlorous acid-inducing lung epithelial cell injury in vitro, role of anion transport. J. Clin. Invest. 93:1994;606-614.
22. Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259:1984;10404-10413.
23. Weiss S.J.R., Klein A., Slivka A., Wei M. Chlorination of taurine by human neutrophils: Evidence for hypochlorous acid generation. J. Clin. Invest. 70:1982;598-607.
24. Park E., Quinn M.R., Wright C.E., Schuller-Levis G. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J. Leukoc. Biol. 54:1993;119-124.
25. Park E., Schuller-Levis G., Quinn M.R. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J. Immunol. 154:1995;4778-4784.
26. Park E., Alberti J., Quinn M.R., Schuller-Levis G. Taurine chloramine inhibits production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv. Exp. Med. Biol. 442:1998;177-182.
27. Park E., Jia J-H., Quinn M.R., Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin. Immunol. 102:2002;179-184.
28. Choray M., Kontny E., Marcinkiewicz J., Maslinski W. Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids. 23:2002;407-413.
29. Kwasny-Krochin B., Bobek M., Kontny E., Gluszko P., Biedron R., Chain B.M., Maslinski W., Marcinkiewicz J. Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. Amino Acids. 23:2002;419-426.
30. Ibrahim S.M., Koczan D., Thiesen H.J. Gene-expression profile of collagen-induced arthritis. J. Autoimmune Dis. 18:2002;159-167.
31. Kontny E., Szczepanska K., Kowalczewski J., Kurowska M., Janicka I., Marcinkiewicz J., Maslinski W. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 43:2000;2169-2177.
32. Barua M., Liu Y., Quinn M.R. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: decreased NF-κB activation and IκB kinase activity. J. Immunol. 167:2002;2275-2281.
33. Marcinkiewicz J., Grabowska A., Bereta J., Stelmaszynska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol. 58:1995;667-674.
34. Suzuki T., Suzuki T., Wada T., Saigo K., Watanabe K. Taurine as a constituent of mitochondrial tRNA: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21:2002;6581-6589.
35. Kanayama A., Inoue J., Sugita-Konishi Y., Shimizu M., Miyamoto Y. Oxidation of IκBα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. J. Biol. Chem. 277:2002;24049-24056.
36. Reymond I., Sergeant A., Tappaz M. Molecular cloning and sequence analysis of the cDNA encoding rat liver cysteine sulfinate decarboxylase (CSD). Biochim. Biophys. Acta. 1307:1996;152-156.
37. Kaisaki P.J., Jerkin A.A., Goodspeed D.C., Steel R.D. Cloning and characterization of rat cysteine sulfinic acid decarboxylase. Biochim. Biophys. Acta. 1262:1995;79-82.
38. Park E., Park S.Y., Wang C., Xu J., LaFauci G., Schuller-Levis G. Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissues. Biochim. Biophys. Acta. 1574:2002;403-406.
39. Hosokawa Y., Matsumoto A., Oka J., Itakura H., Yamaguchi K. Isolation and characterization of a complementary DNA for rat liver cysteine dioxygenase. Biochem. Biophys. Res. Commun. 168:1990;473-478.
40. Bella D.L., Kwon Y.H., Hirschberger L.L., Stipanuk M.H. Post-transcriptional regulation of cysteine dioxygenase in rat liver. Adv. Exp. Med. Biol. 483:2000;71-85.
41. Han X., Budreau A.M., Chesney R.W. Cloning and characterization of the promoter region of the rat taurine transporter (Tau T) gene. Adv. Exp. Med. Biol. 483:2000;97-108.
42. Smith K.E., Borden L.A., Wang C.D., Hartig P.R., Branchek T.A., Weinshank R.L. Cloning and expression of a high affinity taurine tansporter from rat brain. Mol. Pharmacol. 42:1992;563-569.
43. Patel A., Rochelle J.M., Jones J.M., Sumegi G., Uhl G.R., Seldin M.F., Meisler M.H., Gregor P. Mapping of the taurine transporter gene to mouse chromosome 6 and to the short arm of human chromosome 3. Genomics. 1:1995;314-317.
44. Heller-Stilb B., Van Roeyen C., Rascher K., Hartwig H.G., Huth A., Seeliger M.W., Warskulat U., Haussinger D. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J. 16:2002;231-233.
45. Han X., Patters A.B., Chesney R.W. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells. J. Biol. Chem. 277:2002;39266-39273.
46. Englert R.P., Shacter E. Distinct modes of cell death induced by different reactive oxygen species. J. Biol. Chem. 277:2002;20518-20526.
47. Quinn, M.R. and Schuller-Levis, G.B. (1999) Taurine chloramine, an inhibitor of iNOS expression and a potential modulator of inflammation. In: Molecular and Cellular Biology of Nitric Oxide (Laskin, J. and Laskin, D., Eds.), p. 309. Rekker, New York.